Systemic glucose utilization declines during sleep in man. We tested the hypothesis that this decline in utilization is largely accounted for by reduced brain glucose metabolism. 10 normal subjects underwent internal jugular and radial artery cannulation to determine cerebral blood flow by N20 equilibrium technique and to quantitate cross-brain glucose and oxygen differences before and every 3 h during sleep. Sleep stage was graded by continuous electroencephalogram, and systemic glucose turnover was estimated by isotope dilution. Brain glucose metabolism fell from 33.6±2.2 ,gmol/100 g per min (mean±SE) before sleep (2300 h) to a mean nadir of 24.3±1.1 gmol/100 g per min at 0300 h during sleep (P = 0.001). Corresponding rates of systemic glucose utilization fell from 13.2±0.8 to 11.0±0.5 gmol/ kg per min (P = 0.003). Diminished brain glucose metabolism was the product of a reduced arteriovenous glucose difference, 0.643±0.024 to 0.546±0.020 mmol/liter (P = 0.002), and cerebral blood flow, 50.3±2.8 to 44.6±1.4 cc/ 100 g per min (P = 0.021). Brain oxygen metabolism fell commensurately from 153.4±11.8 to 128.0±8.4 Mmol/100 g per min (P = 0.045). The observed reduction in brain metabolism occurred independent of stage of central nervous system electrical activity (electroencephalographic data), and was more closely linked to duration of sleep. We conclude that a decline in brain glucose metabolism is a significant determinant of falling rates of systemic glucose utilization during sleep. (J. Clin. Invest. 1994. 93:529-535.) Key words: brain * glucose metabolism * oxygen metabolism , sleep * electroencephalogram
Introduction
Major changes in metabolism occur during sleep. These alterations include such diverse events as decrements in central nervous system electrical activity (1) , reduced basal metabolic rate (2) , decreased cardiac output (3), as well as concomitant reductions in rates of systemic glucose turnover in normal (4) and diabetic humans (5) . In direct response to sleep, adrenocorticotrophin (6) , and growth hormone (7) are released from the anterior pituitary and exert major influences on systemic glucose metabolism during the ensuing hours (8) (9) (10) . Two recent reviews consolidate the fragments of our present knowl-edge ofthe metabolism of sleep (11, 12) , yet substantial details regarding interrelationships between brain and whole body fuel kinetics are incomplete.
Despite the above mentioned well-known physiologic responses during sleep, direct relationships between brain glucose metabolism and falling systemic glucose turnover have never been investigated. Mangold demonstrated stable cerebral blood flow and oxygen consumption in sleep-deprived humans before sleep and immediately after the onset ofit (13) . Unfortunately, these early studies were not continued though the remainder of the sleep period, and quantification of brain glucose metabolism was not included. Subsequently, a number of investigations have quantitated cerebral blood flow (14) (15) (16) , oxygen metabolism ( 1 7), or glucose metabolism (18) (19) (20) (21) immediately before the onset of sleep and generally once more during the night. None of these investigations included serial, simultaneous measurements of whole brain blood flow with oxygen and glucose metabolism to evaluate any direct effect that duration of sleep might have on these parameters. Likewise, no previous investigation has included measurement of systemic glucose turnover to assess potential associations with central nervous system metabolism. The brain's major fuel is glucose, and during the postabsorptive period, brain glucose metabolism accounts for > 50% of systemic glucose utilization (22) . Because ofthe major contribution the brain plays in total glucose consumption, it is reasonable to suggest that minor decrements in brain glucose metabolism could account for a substantial part of the fall in systemic glucose metabolism during the night. In this investigation, we demonstrate that whole brain glucose metabolism falls in parallel with systemic glucose metabolism and quantitatively accounts for a significant fraction of the reduction observed during sleep in normal humans.
Methods
Subjects. 12 normal volunteers (7 men and 5 women) gave their informed consent to participate in investigations approved by the Human Research Review Committee at the University of New Mexico. Their ages were between 19 and 39 (mean±SE, 25±2 yr). All were within 10% of their ideal body weight. None was taking any medication, and all had normal screening laboratory chemistry studies before being included for participation.
Protocol Left radial arterial and antecubital intravenous cannulas were introduced for blood sampling and infusions, respectively. 2 h before beginning blood sampling for glucose kinetics, a primed continuous infusion of 6,6-D2-glucose was started to allow estimation of rates of systemic glucose production and utilization.
Measurements ofcerebral blood flow were conducted after the technique of Kety and Schmidt (23) and are described in detail below. In general, two measurements were made before sleep and then repeated during sleep at -0100, 0300, and 0500 h. All but one individual was able to sleep the entire night. This subject remained awake throughout the night, and his data are not included in further group analyses. Cerebral blood flow was determined by having subjects rest with their eyes closed in a small plastic hood with air flow maintained at 30 liter/min. Air flow was continued throughout the night so as not to wake subjects by interrupting and restarting the flow. 9% nitrous oxide was introduced at the start of each blood flow measurement while blood was withdrawn continuously from the jugular venous and arterial vessels at 7 cc/min by a syringe pump (model 22; Harvard Apparatus, South Natick, MA). Samples ofblood (0.3 cc) for N20 content were collected simultaneously from the arterial and jugular venous cannulas at 30-s intervals for 6 min and then every 2 min until equilibrium was established at 20 min. Arterial and jugular venous samples for oxygen saturation and glucose concentration were collected at the end of each blood flow determination. Glucose concentration was quantitated by glucose oxidase technique on a glucose analyzer (Beckman Instruments, Fullerton, CA) with each sample determined 10 times to yield coefficients of variation of 0.5% in the range of glucose concentrations encountered. Oxygen saturation of hemoglobin was determined on an optical diffraction grating instrument (OSM3; Radiometer, Copenhagen, Denmark) with a coefficient of variation of 0.85%.
An electroencephalograph instrument (model 6SS; Grass Instrument Co, Quincy, MA) was used to monitor the eight channel continuous EEG recording. Sleep was staged according to Rechtschaffen and Kales (24) . Arterial blood for insulin, growth hormone, glucagon, and systemic glucose kinetics was collected hourly. The venous nitrous oxide concentration reached equilibrium with the arterial compartment in all but one subject, and for that person was taken as evidence of contamination of venous return from extracerebral structures (25). The data for this individual were excluded from further analysis, leaving 10 subjects for data comparison.
Because rates of systemic glucose production and utilization were higher than expected basal values seen in other studies performed under normal postabsorptive conditions (26, 27) , we postulated that a portion ofthe total systemic glucose production during the initial hours of sleep was caused by ongoing gut glucose absorption. Seven of the above subjects returned to be fed their final meal before sleep at 1200 h. The meal was identical to the one they had previously consumed by 1730 h. At 2000 h, a primed continuous infusion of 6,6-D2-glucose was begun to allow estimation of rates of systemic glucose turnover. Samples for glucose and glucose kinetics were collected every 60 min during the night while the subjects slept.
Analytical methods. Plasma insulin (28), C-peptide (28), glucagon (29) , and growth hormone (30) were measured by radioimmunoassay. Samples for glucose turnover were prepared as previously described (31 ) , and rates of glucose production and utilization were calculated from modified forms of Steel's nonsteady state formulas (31 ) . Samples were analyzed for changes in trace amounts of N20 content with a N20 trace infrared spectrophotometer (Traverse Medical Monitors, Saline, MI) after the method of Robertson et al. (32) .
Calculations and statistical methods. Cerebral blood flow (CBF) was calculated from the following form of the Fick equation (23):
where Veq is the relative concentration of N20 at equilibrium, and S is the partition coefficient of nitrous oxide between blood and brain, known to be 1.0 (23) . The integrated area between the arterial and venous nitrous oxide curves, the denominator of the above equation, was calculated by simultaneous curve fitting ofthe arterial, and venous data sets to the class of sigmoidal curves were predicted by the equation:
where A is the minimum point of the curve, b is the slope at the midpoint of the curve, C is the middle point of the curve, and D is the maximum point of the curve. Multiple iterations with forced convergence at equilibrium were performed with the SAS Procedure NLIN using a derivative-free option (33) to provide the coefficients that best described each set of curves. The derived coefficients were then used to generate data points every 0.1 min, and sequential trapezoidal summation was used to calculate the final area between the curves. Brain glucose metabolism is the product ofthe arterialjugular venous glucose difference and the calculated cerebral blood flow. Brain oxygen metabolism was calculated similarly. Comparisons of interest were made with two-tailed paired Student's t tests. Changes in glucose kinetics, glucose concentration, and hormone levels were made by repeated measures analysis of variance (33) . Results
Glucose concentration and rates ofsystemic glucose production and utilization ( Fig. 1 ). Systemic glucose concentration appeared to decline slightly during the night, but this change failed to achieve significance. Rates ofsystemic glucose production and utilization declined in parallel until the final hours of the night and then plateaued at normal fasting rates (ANOVA, P < 0.002).
Growth hormone, insulin, C-peptide, and glucagon levels ( Fig. 2) . Mean growth hormone values rose significantly during the night (P < 0.01). Individual growth hormone spikes were observed at differing times in each individual during sleep. The mean, peak growth hormone concentration was 59 1.6±97.1 pmol/liter (13 Comparison of2300 h (presleep) and 0300 h rates ofbrain metabolism (Table I ). The mean rate brain glucose metabolism immediately before sleep (2300 h) and the mean rate at 0300 h are summarized in Table I . Overall, there was a 27% fall in brain glucose metabolism during sleep (P = 0.001). This decrement was the result of an overall 15% decrease in the arterial-venous glucose difference, P = 0.002, and a 7.3% decrease in cerebral blood flow, P = 0.021. The corresponding rates ofbrain oxygen metabolism fell by 12.0%, P = 0.045. The ratio of brain oxygen/glucose metabolism increased from 4.85±0.13 to 5.33±0.22, P = 0.05. Related rates of systemic glucose production and utilization fell 19. 1%, P = 0.003. Quantitatively, the change in the amount of glucose each subject's whole brain used, calculated by multiplying individual rates of brain glucose metabolism by the subject's brain weight (derived from nomograms of normal brain weight based on age and sex [(34]), fell from 390.1±27.2 to 320.2± 13.9 prmol /min (P = 0.005), while estimated whole body glucose utilization (individual systemic kinetic data multiplied by the subject's body weight) fell from 976±37 to 874±20 Mrmol/min (P = 0.003). Therefore, the fall in brain glucose metabolism is a significant contributor to the fall in whole body systemic glucose utilization.
Comparison of nocturnal rates ofsystemic glucose utilization occurring after varYing time interval fromfinal meal before sleep (Fig. 4) . Rates of systemic glucose turnover fell significantly on both study nights (2200 vs 0400 h, P < 0.002). At -10 h into the fast during each of the investigations (e.g., at 0400 h, when the meal was served at 1730 h [closed bars], and at 2200 h, when the meal was served at 1200 h [open bars]), there was no significant difference between rates of glucose production. Rate of glucose production at 2200 h (presleep) was significantly lower when the interval after the previous meal was prolonged (P < 0.001 ), thus supporting the concept that a portion, but not all, of systemic glucose production after a normally timed evening meal is most likely caused by ongoing food absorption (i.e., a combination of the endogenous glucose production and gut glucose absorption).
Brain glucose metabolism and systemic glucose utilization in one subject unable to sleep throughout the night (Fig. 5) We indirectly assessed the contribution that continuing gut glucose absorption might make to the total systemic glucose production (gut plus other endogenous sources) by having the subjects consume their final meal before sleep at 1200 h. By doing so, the period of fasting (-10 h) before initial kinetic data were collected at 2200 h was comparable to other metabolic investigations conducted during the day with normal basal rates of systemic glucose production, -11 mol/kg per min, being observed before sleep vs nearly 15 ,qmol/kg per min when the meal was provided at 1700 h (Fig. 4) . Investigations conducted by Firth (35) sulin-dependent diabetes mellitus that food absorption, assessed by labeling a mixed meal with glucose deuterated in the second position, occurs for 8-9 h (37). Based on these observations, we would suggest that most nocturnal metabolic studies that include isotopic glucose turnover are measuring, in part, ongoing gut glucose absorption from the evening meal during the early part of sleep. In our study, after a longer fast, and presumably in a true postabsorptive state, a significant decrement in systemic glucose production during sleep was still observed, consistent with the concept that brain glucose metabolism declines as the direct result of sleep, although we did not specifically assess this possibility.
Previous studies by Clore (4) noted that part, but not all, of the fall in systemic glucose production and utilization after a normally timed evening meal could be blocked by keeping subjects awake through the night. When combined with data from our single subject who remained throughout the night (Fig. 5) and who had no change in brain glucose metabolism (while having a preserved decline in systemic glucose utilization presumably caused by the final absorption of glucose from the gut), one might suggest that the combination of sleep deprivation and studying subjects in a true postabsorptive (not postprandial) state would obliterate the fall in systemic glucose turnover. This hypothesis has yet to be tested. However, if the sleeping group's mean fall in brain glucose metabolism is representative of the usual change that occurs during normal sleep, then the individual who remained awake all night would have experienced an additional 9.3 ,gmol/ 100 g per min (Fig. 1 ) had he slept. Multiplying this mean reduction by the nonsleeper's estimated brain weight (34), and dividing that product by his total body weight, an additional 1.58 ,gmol/kg per min fall in systemic glucose utilization could be expected by 0300 h. Subtracting this further decrement from his original 0300 h data yields a rate of systemic utilization still well within the 95% confidence interval for the sleeping group (shaded area, Fig. 5 ).
The central nervous system has been known to be directly involved in peripheral glucose metabolism since Claude Bernard pierced the floor of the fourth ventricle of rabbits and induced permanent diabetes (38) . Biggers et al. demonstrated that by maintaining brain normoglycemia while allowing whole body hypoglycemia in dogs, the normal peripheral counterregulatory hormone responses (epinephrine, norepinephrine, cortisol, and pancreatic polypeptide) were substantially blunted (39). Thus, the brain appears to be indirectly involved in preserving and regulating systemic glucose production when threatened with inadequate glucose supplies. Although the current investigation demonstrates an interesting concordance (4) . Because of a concomitant increase in glucose utilization that occurred in those studies, there was no change in glucose concentration. In general, such increments occur during the hours of 0500 to 0800 h and are thought to be related to secretion of growth hormone during the first hours of sleep (43) . In patients with insulin-dependent diabetes, this increased rate of hepatic glucose production generally results in a rise in plasma glucose concentration when coupled with stable insulin levels and is referred to as the "dawn phenomena" (44) . During these investigations, we failed to observe any increase in glucose production and utilization during the final hours of observed sleep, most likely because ofthe fact that our final data was collected at 0500 h, before the rise in glucose production normally begins. If one extrapolates this proposal to patients with insulin-dependent diabetes, where modest hyperinsulinemia occurs routinely during the night, then the stage should be set for nocturnal hypoglycemia. In the Diabetes Control and Complications Trial, a multicenter, randomized trial comparing near normalization of blood glucose levels to standard insulin therapy in > 1,400 patients with insulin-dependent diabetes, the insulin replacement schemes used routinely produce stable or moderate hyperinsulinemia during sleep (45) . Consistent with the above extrapolation, > 50% of the severe hypoglycemic events experienced by the patients in the Diabetes Control and Complications Trial have occurred temporally with our reported nocturnal nadirs in brain glucose utilization and systemic glucose production (46).
In the current study, the overall pattern of brain oxygen metabolism fell gradually over the night. The magnitude ofthe change was not nearly as great as that observed for glucose consumption but is in keeping with the overall reduction in systemic oxygen utilization reported by Brebbia (47) . Only Mangold ( 13) and Madsen ( 17) have previously investigated nocturnal brain oxygen metabolism, and they came to disparate conclusions. Mangold's original observation of unchanged oxygen utilization has been questioned, since when one of the six participants he studied is excluded from analysis, there is a statistically significant decrease in oxygen metabolism. Madsen found a 25% reduction in brain oxygen metabolism during deep sleep and an increase during REM sleep in subjects studied on several different nights. In the present investigation, the quantity of oxygen required (on a molar basis) to metabolize glucose (at the nocturnal glucose metabolism nadir) was significantly greater than the oxygen/glucose ratio seen before sleep. Several possible metabolic events could explain this observation: (a) oxidative glucose disposal could continue unchanged while there is a decrease in nonoxidative glucose disposal in brain tissue (i.e., less glycogen formation); (b) an alternate fuel source such as ketone bodies may be oxidized to meet metabolic demands as glucose metabolism falls off; or (c) there is a relative decrease in anaerobic metabolism. With respect to the first possibility, the brain is unable to synthesize or store more than a few minutes' worth of glucose for later use (48) . Thus, a large enough decrease in glycogen synthesis to account for the 25% decrease in systemic glucose utilization we report seems unlikely, although no data exist on glycogen content before and after sleep. The second explanation also seems unlikely, since we failed to observe an increase in the arteriovenous ketone difference across the brain (data not shown). Other substrates (such as nonesterified fatty acids and amino acids) are not major energy substrates for brain metabolism (42) and were not assessed in this investigation. The final explanation is perhaps most reasonable. Fox et al. have demonstrated that during visual stimulation, brain glucose metabolism increases in the visual cortex, while oxygen utilization remains constant (49) , implying that a relative increase in anaerobic metabolism occurs with increased neuronal activity. During sleep, cortical neuronal activity decreases (the opposite outcome of the Fox experiment) with median firing rates falling by 25% comparing wakefulness to slow wave sleep ( 1). In further support of an overall reduction in electrical activity, we and others ( 14-16) have observed a decline in cerebral blood flow, a parameter generally believed to be coupled to neuronal activity (50) . Therefore, if sleep is viewed physiologically as a relative opposite of the wakeful state (e.g., less visual stimulation and reduced overall neuronal activity), and by the above reasoning results in a decrease in anaerobic glycolysis, then the oxygen/ glucose ratio would be expected to rise. In summary, whether or not the primary metabolic event responsible for the fall in whole body glucose production and utilization is a fall in brain glucose metabolism during sleep remains unclear. However, several independent conclusions can be made: (a) rates ofbrain glucose and oxygen metabolism decrease during the night (the former more than the later); (b) quantitatively, the fall in brain glucose utilization accounts for a significant part of the decrement in measured peripheral glucose utilization; (c) the fall in brain glucose metabolism occurs secondary to reduced cerebral blood flow and diminished brain glucose arteriovenous glucose difference; and (d) these changes in brain energy and flow dynamics during sleep occur independent of stage of slow wave electrical activity (except during REM sleep where brain metabolism increases in most subjects) and instead appear to be more related to duration of sleep.
